Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL
| Autor: | Constantine S. Tam, Emma L Hiscutt, Dale Jobson, Christopher McCormack |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cancer Research
medicine.medical_specialty Skin Neoplasms T cell Ipilimumab 03 medical and health sciences 0302 clinical medicine Immune system Internal medicine medicine Humans Melanoma B cell Hematology business.industry medicine.disease Leukemia Lymphocytic Chronic B-Cell Leukemia Nivolumab medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Cancer research Anemia Hemolytic Autoimmune business 030215 immunology medicine.drug |
| Zdroj: | Leukemia & Lymphoma. 62:992-994 |
| ISSN: | 1029-2403 1042-8194 |
| DOI: | 10.1080/10428194.2020.1846735 |
| Popis: | Check point inhibitors stimulate the immune systems antitumour response by impairing T cell inhibitory signaling pathways [1]. Ipilimumab is a widely used check point inhibitor which acts on cytoto... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|